BRIEF published on 10/24/2024 at 07:35, 1 year 9 months ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 9 months ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma présente une nouvelle boîte à outils de fabrication de vecteurs lentiviraux Thérapie Génique Produits Biopharmaceutiques Thérapies Avancées Vecteurs Lentiviraux Services De Fabrication
BRIEF published on 09/03/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 11 months ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 2 years 1 month ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
BRIEF published on 07/11/2024 at 14:05, 2 years 1 month ago Rentschler Biopharma dévoile une nouvelle ligne de production dans le Massachusetts Rentschler Biopharma Produits Biopharmaceutiques Massachusetts Ligne De Production
PRESS RELEASE published on 07/11/2024 at 14:00, 2 years 1 month ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 2 years 2 months ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 2 years 2 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
Published on 08/21/2026 at 02:30, 9 hours 56 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 12 hours 26 minutes ago Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 13 hours 26 minutes ago EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 14 hours 26 minutes ago Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/20/2026 at 15:30, 20 hours 56 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/21/2026 at 12:05, 20 minutes ago METLEN conducts First Fire on Waste at the Protos ERF plant in Cheshire
Published on 08/21/2026 at 11:46, 40 minutes ago 2026 Annual General Meeting: Three Pillars – One Strategy
Published on 08/21/2026 at 11:28, 57 minutes ago EQS-Adhoc: Borussia Dortmund GmbH & Co. KGaA: Borussia Dortmund publishes preliminary figures for the 2025/2026 financial year
Published on 08/21/2026 at 11:28, 57 minutes ago Circus Holds Successful 2026 Annual General Meeting as Global AI Robotics Rollout Progresses
Published on 08/21/2026 at 11:00, 1 hour 26 minutes ago O’KEY GROUP S.A. REPORTS OPERATIONAL AND FINANCIAL RESULTS FOR H1 2026
Published on 08/18/2026 at 18:00, 2 days 18 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 18 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 3 days 1 hour ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
